Sensipar Company Profile

00:32 EST 14th December 2018 | BioPortfolio


News Articles [6 Associated News Articles listed on BioPortfolio]

Sensipar Generics: US Court Victory, FDA Approval Position Piramal For Launch

Just days after Piramal was one of three generic drug sponsors found not to have infringed a Sensipar formulation patent...  

Medicare Payments For Sensipar, Parsabiv Could Be Bellwether For Dialysis Drug Developers

Sensipar/Parsabiv marketer Amgen and three developers of new treatments for anemia emphasize importance to innovation of additional payments outside  Medicare's...  &

Novartis accused of pay-for-delay, while Amgen sues over generic thyroid drug

Novartis are facing a lawsuit for attempts to prevent generic versions of their hypertension treatment Exforge, and Amgen announce they will be suing Accord Healthcare for patent infringement on their...

WellCare To Triple Medicare Part D Membership With Purchase Of Aetna Plans

Divestiture prevents CVS from gaining even more dominance in the stand-alone Medicare Part D sector with its acquisition of Aetna...   

US FDA May Wait Until Late 2019 Before A Cures Hiring Enhancement Is Available

Senior Biomedical Research Service expansion, used to attract elite scientists to federal service, may not be implemented until late 2019;...    

Could Contentious IPR Trade Terms Bloat Healthcare Costs, Sink Pharma’s Image?

Intellectual property rights terms in various trade agreements could have serious ramifications not just on healthcare costs but also on...   

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Sensipar [State of Florida DOH Central Pharmacy]

Sensipar (cinacalcet) Tablets

Sensipar [Amgen, Inc]

These highlights do not include all the information needed to use Sensipar safely and effectively. See full prescribing information for Sensipar. Sensipar (cinacalcet) TabletsInitial U.S. Approval: 20...

PubMed Articles [0 Results]


Clinical Trials [8 Associated Clinical Trials listed on BioPortfolio]

START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism

The purpose of this research is to study the effects and safety of Sensipar approved by the Food and Drug Administration (FDA) in patients with kidney failure who are being treated with di...

Post Transplant Study

Retrospective chart review to gather information on Sensipar patterns of use and effects on biochemical parameters in renal transplant recipients

A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)

Objectives include description of current practices; assessment over time of K/DOQI goals, clinical outcomes, health resource utilization(HRU) and patient reported outcomes (PRO) and the ...

E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events

The purpose of this study is to evaluate the effects of cinacalcet (cinacalcet HCl or Sensipar®/Mimpara®) on cardiovascular events and death in chronic kidney disease (CKD) patients with...

ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism

The purpose of this study is to compare the proportion of chronic kidney disease (CKD) subjects on dialysis receiving Sensipar® and low dose vitamin D or escalating doses of vitamin D alo...

Companies [3 Associated Companies listed on BioPortfolio]

Sensipar® (cinacalcet HCl)

Sensipar® (cinacalcet HCl) is an innovative, first-in-class, oral therapy indicated to treat hyperparathyroidism (excessive levels of parathyroid hormone) caused by chronic kidney disease; it is appr...



NPS Pharmaceuticals

NPS Pharmaceuticals is engaged in the discovery, development and commercialization of therapeutic small molecules and recombinant proteins to treat bone and mineral, gastrointestinal and central nervo...

More Information about "Sensipar" on BioPortfolio

We have published hundreds of Sensipar news stories on BioPortfolio along with dozens of Sensipar Clinical Trials and PubMed Articles about Sensipar for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sensipar Companies in our database. You can also find out about relevant Sensipar Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record